000 01166 a2200313 4500
005 20250512211207.0
264 0 _c19831217
008 198312s 0 0 eng d
022 _a0022-4790
024 7 _a10.1002/jso.2930240208
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMetzger, U F
245 0 0 _aCombined modality treatment of pancreatic cancer: implications for the surgeon.
_h[electronic resource]
260 _bJournal of surgical oncology
_cOct 1983
300 _a107-12 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aClinical Trials as Topic
650 0 4 _aCombined Modality Therapy
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFluorouracil
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aPancreatic Neoplasms
_xdrug therapy
650 0 4 _aRadiotherapy Dosage
700 1 _aKisner, D L
700 1 _aGhosh, B C
773 0 _tJournal of surgical oncology
_gvol. 24
_gno. 2
_gp. 107-12
856 4 0 _uhttps://doi.org/10.1002/jso.2930240208
_zAvailable from publisher's website
999 _c6355580
_d6355580